

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrocyte maturation (GO:0043249) | 9.08721623 |
| 2 | mitochondrial calcium ion homeostasis (GO:0051560) | 8.23180001 |
| 3 | UV protection (GO:0009650) | 7.65723020 |
| 4 | myelin assembly (GO:0032288) | 6.99429983 |
| 5 | hematopoietic stem cell differentiation (GO:0060218) | 6.73291188 |
| 6 | organelle membrane fusion (GO:0090174) | 6.24422177 |
| 7 | nucleotide-excision repair, DNA damage removal (GO:0000718) | 6.21301742 |
| 8 | DNA excision (GO:0044349) | 6.21301742 |
| 9 | 7-methylguanosine mRNA capping (GO:0006370) | 6.06531604 |
| 10 | spinal cord development (GO:0021510) | 6.03978526 |
| 11 | regulation of early endosome to late endosome transport (GO:2000641) | 5.89354471 |
| 12 | 7-methylguanosine RNA capping (GO:0009452) | 5.82977729 |
| 13 | RNA capping (GO:0036260) | 5.82977729 |
| 14 | termination of RNA polymerase I transcription (GO:0006363) | 5.54101990 |
| 15 | hair cell differentiation (GO:0035315) | 5.09843847 |
| 16 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.93782823 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 4.84515571 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.84515571 |
| 19 | negative regulation of organelle assembly (GO:1902116) | 4.79829785 |
| 20 | transcription-coupled nucleotide-excision repair (GO:0006283) | 4.79067609 |
| 21 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.75228310 |
| 22 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 4.57456784 |
| 23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.43176629 |
| 24 | sequestering of actin monomers (GO:0042989) | 4.31499996 |
| 25 | transcription from RNA polymerase I promoter (GO:0006360) | 4.30179213 |
| 26 | protein neddylation (GO:0045116) | 4.28854564 |
| 27 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.26826219 |
| 28 | protein maturation by protein folding (GO:0022417) | 4.25002386 |
| 29 | neuronal ion channel clustering (GO:0045161) | 4.20985801 |
| 30 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 4.17331175 |
| 31 | negative regulation of catenin import into nucleus (GO:0035414) | 4.13584593 |
| 32 | viral transcription (GO:0019083) | 3.98288517 |
| 33 | aldehyde catabolic process (GO:0046185) | 3.97561835 |
| 34 | positive regulation of viral transcription (GO:0050434) | 3.95645941 |
| 35 | translational termination (GO:0006415) | 3.75295887 |
| 36 | DNA damage response, detection of DNA damage (GO:0042769) | 3.73260635 |
| 37 | lipoxygenase pathway (GO:0019372) | 3.66082613 |
| 38 | ribosomal small subunit biogenesis (GO:0042274) | 3.66008206 |
| 39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.64536091 |
| 40 | cotranslational protein targeting to membrane (GO:0006613) | 3.60307204 |
| 41 | protein targeting to ER (GO:0045047) | 3.59403821 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 3.56296055 |
| 43 | ribosomal small subunit assembly (GO:0000028) | 3.52690229 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.46386684 |
| 45 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.45107674 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.43881438 |
| 47 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.42368863 |
| 48 | protein localization to endoplasmic reticulum (GO:0070972) | 3.41226573 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.38668818 |
| 50 | proteasome assembly (GO:0043248) | 3.36831839 |
| 51 | negative regulation of epithelial to mesenchymal transition (GO:0010719) | 3.33937218 |
| 52 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.30239116 |
| 53 | positive regulation of DNA binding (GO:0043388) | 3.27596056 |
| 54 | translational elongation (GO:0006414) | 3.26970292 |
| 55 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.26303604 |
| 56 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.24531327 |
| 57 | autophagic vacuole fusion (GO:0000046) | 3.24162472 |
| 58 | deoxyribonucleotide catabolic process (GO:0009264) | 3.23117762 |
| 59 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.22971724 |
| 60 | maturation of SSU-rRNA (GO:0030490) | 3.20228842 |
| 61 | response to peptidoglycan (GO:0032494) | 3.17522248 |
| 62 | platelet aggregation (GO:0070527) | 3.15877363 |
| 63 | deoxyribose phosphate catabolic process (GO:0046386) | 3.13741050 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.13435152 |
| 65 | execution phase of apoptosis (GO:0097194) | 3.13207101 |
| 66 | regulation of superoxide anion generation (GO:0032928) | 3.12967410 |
| 67 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.12843327 |
| 68 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.12630523 |
| 69 | anatomical structure maturation (GO:0071695) | 3.10688378 |
| 70 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.10388079 |
| 71 | respiratory electron transport chain (GO:0022904) | 3.08626050 |
| 72 | neutrophil activation (GO:0042119) | 3.06043170 |
| 73 | purine nucleotide salvage (GO:0032261) | 3.04283894 |
| 74 | GTP biosynthetic process (GO:0006183) | 3.02367529 |
| 75 | electron transport chain (GO:0022900) | 3.02177282 |
| 76 | pentose-phosphate shunt (GO:0006098) | 3.00853659 |
| 77 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.99083710 |
| 78 | immunoglobulin mediated immune response (GO:0016064) | 2.97027675 |
| 79 | viral life cycle (GO:0019058) | 2.96603114 |
| 80 | pinocytosis (GO:0006907) | 2.96492466 |
| 81 | thrombin receptor signaling pathway (GO:0070493) | 2.95995478 |
| 82 | purine-containing compound salvage (GO:0043101) | 2.95402457 |
| 83 | respiratory burst (GO:0045730) | 2.95105214 |
| 84 | regulation of platelet aggregation (GO:0090330) | 2.94641273 |
| 85 | translational initiation (GO:0006413) | 2.93828710 |
| 86 | cellular protein complex disassembly (GO:0043624) | 2.92610790 |
| 87 | telomere maintenance via recombination (GO:0000722) | 2.92429387 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 2.92235410 |
| 89 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.91884210 |
| 90 | negative regulation of ligase activity (GO:0051352) | 2.91884210 |
| 91 | granulocyte activation (GO:0036230) | 2.89065942 |
| 92 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.88127820 |
| 93 | angiogenesis involved in wound healing (GO:0060055) | 2.87521228 |
| 94 | mitochondrial transport (GO:0006839) | 2.87245841 |
| 95 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.86488919 |
| 96 | phagosome maturation (GO:0090382) | 2.84888766 |
| 97 | nucleotide-excision repair (GO:0006289) | 2.83485820 |
| 98 | pyrimidine nucleoside salvage (GO:0043097) | 2.82652125 |
| 99 | pyrimidine-containing compound salvage (GO:0008655) | 2.82652125 |
| 100 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.82284756 |
| 101 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.81363014 |
| 102 | nucleoside salvage (GO:0043174) | 2.80544867 |
| 103 | response to dietary excess (GO:0002021) | 2.80425626 |
| 104 | translation (GO:0006412) | 2.79564351 |
| 105 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.79151518 |
| 106 | ribosomal large subunit biogenesis (GO:0042273) | 2.79032394 |
| 107 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.78843200 |
| 108 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.78843200 |
| 109 | modulation by symbiont of host immune response (GO:0052553) | 2.78843200 |
| 110 | positive regulation by symbiont of host defense response (GO:0052509) | 2.78843200 |
| 111 | modulation by symbiont of host defense response (GO:0052031) | 2.78843200 |
| 112 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.78843200 |
| 113 | NADPH regeneration (GO:0006740) | 2.78002878 |
| 114 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.75674408 |
| 115 | protein targeting to mitochondrion (GO:0006626) | 2.73705478 |
| 116 | DNA deamination (GO:0045006) | 2.73680874 |
| 117 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.73398301 |
| 118 | pentose metabolic process (GO:0019321) | 2.73359687 |
| 119 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.72664282 |
| 120 | DNA strand elongation (GO:0022616) | 2.72601419 |
| 121 | L-methionine salvage (GO:0071267) | 2.72173632 |
| 122 | L-methionine biosynthetic process (GO:0071265) | 2.72173632 |
| 123 | amino acid salvage (GO:0043102) | 2.72173632 |
| 124 | regulation of viral transcription (GO:0046782) | 2.71961475 |
| 125 | B cell mediated immunity (GO:0019724) | 2.71840932 |
| 126 | extracellular fibril organization (GO:0043206) | 2.70548531 |
| 127 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.70386566 |
| 128 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.70386566 |
| 129 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.70339072 |
| 130 | hydrogen peroxide catabolic process (GO:0042744) | 2.69908474 |
| 131 | protein complex biogenesis (GO:0070271) | 2.69846218 |
| 132 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.68960250 |
| 133 | UTP biosynthetic process (GO:0006228) | 2.68907180 |
| 134 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.68697457 |
| 135 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.68697457 |
| 136 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.68697457 |
| 137 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.68392890 |
| 138 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.67840970 |
| 139 | establishment of protein localization to mitochondrion (GO:0072655) | 2.67762714 |
| 140 | chaperone-mediated protein transport (GO:0072321) | 2.67751744 |
| 141 | positive regulation of mast cell degranulation (GO:0043306) | 2.66816955 |
| 142 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.66816955 |
| 143 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.65281420 |
| 144 | mitochondrion morphogenesis (GO:0070584) | 2.64962583 |
| 145 | amino sugar catabolic process (GO:0046348) | 2.64900701 |
| 146 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.64786421 |
| 147 | adenosine receptor signaling pathway (GO:0001973) | 2.64066289 |
| 148 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.63496472 |
| 149 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.63472021 |
| 150 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.63472021 |
| 151 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.63421400 |
| 152 | positive regulation of viral process (GO:0048524) | 2.62857890 |
| 153 | establishment of mitochondrion localization (GO:0051654) | 2.62242697 |
| 154 | regulation of platelet activation (GO:0010543) | 2.61454015 |
| 155 | nucleotide salvage (GO:0043173) | 2.61224682 |
| 156 | cyclooxygenase pathway (GO:0019371) | 2.58231250 |
| 157 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.56954743 |
| 158 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.56561718 |
| 159 | response to interferon-beta (GO:0035456) | 2.53842968 |
| 160 | fibril organization (GO:0097435) | 2.53480565 |
| 161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53405161 |
| 162 | glucose catabolic process (GO:0006007) | 2.51748179 |
| 163 | deoxyribose phosphate metabolic process (GO:0019692) | 2.51330300 |
| 164 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.47649642 |
| 165 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.47649642 |
| 166 | NADH dehydrogenase complex assembly (GO:0010257) | 2.47649642 |
| 167 | leukocyte degranulation (GO:0043299) | 2.47640364 |
| 168 | regulation of superoxide metabolic process (GO:0090322) | 2.47470348 |
| 169 | platelet dense granule organization (GO:0060155) | 2.46571111 |
| 170 | regulation of leukocyte degranulation (GO:0043300) | 2.44370146 |
| 171 | response to host immune response (GO:0052572) | 2.43378323 |
| 172 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.43378323 |
| 173 | mitochondrial calcium ion transport (GO:0006851) | 11.3628703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.40716148 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.39391604 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.35959115 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.30047431 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.21373611 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.03565025 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.97934463 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.88438427 |
| 9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.78327482 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.75921757 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.68490299 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.61501846 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.59862756 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43803835 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43336071 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.32507739 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.24753724 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14642688 |
| 19 | STAT1_20625510_ChIP-Seq_HELA_Human | 2.09913732 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09795981 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.05822947 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01945395 |
| 23 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.97095000 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.96414516 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.89172188 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88445059 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.87350889 |
| 28 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.86897751 |
| 29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.80363682 |
| 30 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.79010221 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.76949099 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.76779837 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72006655 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.71255956 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.67531789 |
| 36 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.62447322 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62381698 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57016703 |
| 39 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.55718486 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.55600416 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55078066 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54996800 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53919432 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52534207 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51272295 |
| 46 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50450666 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.50262062 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.49506478 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48253459 |
| 50 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.45740766 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45526993 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45141860 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44687851 |
| 54 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.43594756 |
| 55 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42931792 |
| 56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42126451 |
| 57 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.41578096 |
| 58 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.39542483 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38794917 |
| 60 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.38079651 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37753521 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37338499 |
| 63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37231569 |
| 64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.36745911 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35150160 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34979440 |
| 67 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34582795 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34497534 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33821689 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31842153 |
| 71 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.31073631 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30371607 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.29793068 |
| 74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29777854 |
| 75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29493663 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29467555 |
| 77 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28790328 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28784006 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28250842 |
| 80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26479306 |
| 81 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25981780 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24576931 |
| 83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.24002846 |
| 84 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.22596056 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21160465 |
| 86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.20912617 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20488090 |
| 88 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19432249 |
| 89 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.19063171 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18202422 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16404085 |
| 92 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14515512 |
| 93 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.13840445 |
| 94 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13817936 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13401639 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 1.13165856 |
| 97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12427626 |
| 98 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12427626 |
| 99 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12427626 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11694714 |
| 101 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.11075234 |
| 102 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10866205 |
| 103 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10217923 |
| 104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10152290 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09861319 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09136555 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08590835 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07331277 |
| 109 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.07019521 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06355248 |
| 111 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.06338817 |
| 112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06105268 |
| 113 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05405463 |
| 114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05196594 |
| 115 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04872826 |
| 116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04658363 |
| 117 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04233955 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04134162 |
| 119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04090851 |
| 120 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.03890352 |
| 121 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02643575 |
| 122 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01881675 |
| 123 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01092703 |
| 124 | P68_20966046_ChIP-Seq_HELA_Human | 0.98768054 |
| 125 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97930487 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97256032 |
| 127 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96592671 |
| 128 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95682129 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94537100 |
| 130 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94528497 |
| 131 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94485451 |
| 132 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94397063 |
| 133 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.93885299 |
| 134 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92936051 |
| 135 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.92510286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 8.26928509 |
| 2 | MP0005464_abnormal_platelet_physiology | 5.52036905 |
| 3 | MP0002938_white_spotting | 5.02963982 |
| 4 | MP0003878_abnormal_ear_physiology | 4.33617609 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 4.33617609 |
| 6 | MP0002102_abnormal_ear_morphology | 4.29194038 |
| 7 | MP0010307_abnormal_tumor_latency | 3.71908882 |
| 8 | MP0003786_premature_aging | 3.11694298 |
| 9 | MP0000003_abnormal_adipose_tissue | 3.09406998 |
| 10 | MP0000749_muscle_degeneration | 2.85520607 |
| 11 | MP0008004_abnormal_stomach_pH | 2.42188365 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.40575628 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.34033555 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.29275545 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.23004676 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.12328977 |
| 17 | MP0003646_muscle_fatigue | 2.11904975 |
| 18 | MP0003075_altered_response_to | 2.11845690 |
| 19 | MP0009840_abnormal_foam_cell | 2.00469482 |
| 20 | MP0002132_abnormal_respiratory_system | 1.94964686 |
| 21 | MP0003879_abnormal_hair_cell | 1.85392107 |
| 22 | MP0005671_abnormal_response_to | 1.82169624 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 1.81444602 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.81444602 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 1.77617289 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.77338471 |
| 27 | MP0003436_decreased_susceptibility_to | 1.76234834 |
| 28 | MP0005332_abnormal_amino_acid | 1.75574578 |
| 29 | MP0003186_abnormal_redox_activity | 1.74213140 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.74053802 |
| 31 | MP0006082_CNS_inflammation | 1.64453848 |
| 32 | MP0005083_abnormal_biliary_tract | 1.63770389 |
| 33 | MP0004510_myositis | 1.63583024 |
| 34 | MP0003724_increased_susceptibility_to | 1.60163512 |
| 35 | MP0003303_peritoneal_inflammation | 1.59037849 |
| 36 | MP0000685_abnormal_immune_system | 1.56451626 |
| 37 | MP0005165_increased_susceptibility_to | 1.55360279 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.52649426 |
| 39 | MP0005375_adipose_tissue_phenotype | 1.50784529 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.49230301 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.48296124 |
| 42 | MP0008058_abnormal_DNA_repair | 1.45803343 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.44054993 |
| 44 | MP0004742_abnormal_vestibular_system | 1.42711286 |
| 45 | MP0005451_abnormal_body_composition | 1.41541376 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.38168447 |
| 47 | MP0000751_myopathy | 1.37844145 |
| 48 | MP0000343_altered_response_to | 1.37334516 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.37075931 |
| 50 | MP0009278_abnormal_bone_marrow | 1.35703692 |
| 51 | MP0001485_abnormal_pinna_reflex | 1.34099731 |
| 52 | MP0002398_abnormal_bone_marrow | 1.32452705 |
| 53 | MP0009764_decreased_sensitivity_to | 1.30903508 |
| 54 | MP0006035_abnormal_mitochondrial_morpho | 1.30163058 |
| 55 | MP0003866_abnormal_defecation | 1.27815653 |
| 56 | MP0009785_altered_susceptibility_to | 1.25052683 |
| 57 | MP0002429_abnormal_blood_cell | 1.21587858 |
| 58 | MP0005501_abnormal_skin_physiology | 1.19970064 |
| 59 | MP0005508_abnormal_skeleton_morphology | 1.17312358 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.16390749 |
| 61 | MP0000716_abnormal_immune_system | 1.15850021 |
| 62 | MP0005390_skeleton_phenotype | 1.14447344 |
| 63 | MP0002419_abnormal_innate_immunity | 1.14403238 |
| 64 | MP0005000_abnormal_immune_tolerance | 1.14386611 |
| 65 | MP0002722_abnormal_immune_system | 1.10399507 |
| 66 | MP0000490_abnormal_crypts_of | 1.07049652 |
| 67 | MP0009763_increased_sensitivity_to | 1.05964580 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.05872501 |
| 69 | MP0001542_abnormal_bone_strength | 1.04621107 |
| 70 | MP0005025_abnormal_response_to | 1.04248429 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.98706497 |
| 72 | MP0000750_abnormal_muscle_regeneration | 0.98395106 |
| 73 | MP0001663_abnormal_digestive_system | 0.98085044 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.96963883 |
| 75 | MP0003136_yellow_coat_color | 0.96902245 |
| 76 | MP0000858_altered_metastatic_potential | 0.96847567 |
| 77 | MP0005166_decreased_susceptibility_to | 0.96691722 |
| 78 | MP0004084_abnormal_cardiac_muscle | 0.96148198 |
| 79 | MP0003828_pulmonary_edema | 0.95848642 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.95218366 |
| 81 | MP0004947_skin_inflammation | 0.94723271 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92668199 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.89816454 |
| 84 | MP0001851_eye_inflammation | 0.89555013 |
| 85 | MP0000747_muscle_weakness | 0.88163894 |
| 86 | MP0002452_abnormal_antigen_presenting | 0.88091235 |
| 87 | MP0002405_respiratory_system_inflammati | 0.86833948 |
| 88 | MP0002254_reproductive_system_inflammat | 0.85036527 |
| 89 | MP0004036_abnormal_muscle_relaxation | 0.84605451 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.84415380 |
| 91 | MP0006054_spinal_hemorrhage | 0.83179403 |
| 92 | MP0008874_decreased_physiological_sensi | 0.81991554 |
| 93 | MP0005410_abnormal_fertilization | 0.81903843 |
| 94 | MP0005408_hypopigmentation | 0.81812274 |
| 95 | MP0008873_increased_physiological_sensi | 0.80809306 |
| 96 | MP0003011_delayed_dark_adaptation | 0.80390080 |
| 97 | MP0003195_calcinosis | 0.79490325 |
| 98 | MP0008932_abnormal_embryonic_tissue | 0.78415833 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.76846727 |
| 100 | MP0003693_abnormal_embryo_hatching | 0.75813041 |
| 101 | MP0010386_abnormal_urinary_bladder | 0.74974256 |
| 102 | MP0002723_abnormal_immune_serum | 0.74697571 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.74196699 |
| 104 | MP0004145_abnormal_muscle_electrophysio | 0.73815335 |
| 105 | MP0000920_abnormal_myelination | 0.73332690 |
| 106 | MP0004134_abnormal_chest_morphology | 0.72153193 |
| 107 | MP0000249_abnormal_blood_vessel | 0.70741718 |
| 108 | MP0000604_amyloidosis | 0.70366122 |
| 109 | MP0005365_abnormal_bile_salt | 0.70356116 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.70301068 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.68405928 |
| 112 | MP0002736_abnormal_nociception_after | 0.68378701 |
| 113 | MP0003795_abnormal_bone_structure | 0.68184166 |
| 114 | MP0001790_abnormal_immune_system | 0.67701610 |
| 115 | MP0005387_immune_system_phenotype | 0.67701610 |
| 116 | MP0005174_abnormal_tail_pigmentation | 0.67463746 |
| 117 | MP0001853_heart_inflammation | 0.67337495 |
| 118 | MP0003763_abnormal_thymus_physiology | 0.66489932 |
| 119 | MP0000681_abnormal_thyroid_gland | 0.66037497 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.65985833 |
| 121 | MP0001958_emphysema | 0.65950695 |
| 122 | MP0002282_abnormal_trachea_morphology | 0.65462480 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.64053376 |
| 124 | MP0008469_abnormal_protein_level | 0.63801834 |
| 125 | MP0005330_cardiomyopathy | 0.63700124 |
| 126 | MP0005381_digestive/alimentary_phenotyp | 0.63432925 |
| 127 | MP0001819_abnormal_immune_cell | 0.63412955 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.63307049 |
| 129 | MP0002277_abnormal_respiratory_mucosa | 0.63186844 |
| 130 | MP0002972_abnormal_cardiac_muscle | 0.62810824 |
| 131 | MP0002933_joint_inflammation | 0.62504804 |
| 132 | MP0005193_abnormal_anterior_eye | 0.62441874 |
| 133 | MP0002420_abnormal_adaptive_immunity | 0.61436805 |
| 134 | MP0009379_abnormal_foot_pigmentation | 0.61045406 |
| 135 | MP0003191_abnormal_cellular_cholesterol | 0.60971872 |
| 136 | MP0001879_abnormal_lymphatic_vessel | 0.60464760 |
| 137 | MP0001727_abnormal_embryo_implantation | 0.60456038 |
| 138 | MP0003172_abnormal_lysosome_physiology | 0.60150417 |
| 139 | MP0000372_irregular_coat_pigmentation | 0.59367034 |
| 140 | MP0002295_abnormal_pulmonary_circulatio | 0.59056990 |
| 141 | MP0000358_abnormal_cell_content/ | 0.58392736 |
| 142 | MP0001800_abnormal_humoral_immune | 0.58373180 |
| 143 | MP0003718_maternal_effect | 0.57471159 |
| 144 | MP0008260_abnormal_autophagy | 0.56054685 |
| 145 | MP0003448_altered_tumor_morphology | 0.55847561 |
| 146 | MP0002019_abnormal_tumor_incidence | 0.55283998 |
| 147 | MP0000759_abnormal_skeletal_muscle | 0.53818175 |
| 148 | MP0005670_abnormal_white_adipose | 0.52063751 |
| 149 | MP0003279_aneurysm | 0.51484924 |
| 150 | MP0000689_abnormal_spleen_morphology | 0.50643854 |
| 151 | MP0005084_abnormal_gallbladder_morpholo | 0.50010156 |
| 152 | MP0003329_amyloid_beta_deposits | 0.49971605 |
| 153 | MP0002638_abnormal_pupillary_reflex | 0.49757162 |
| 154 | MP0001905_abnormal_dopamine_level | 0.49255307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 9.12898092 |
| 2 | Entropion (HP:0000621) | 8.97885277 |
| 3 | Poikiloderma (HP:0001029) | 7.36760933 |
| 4 | Decreased subcutaneous fat (HP:0001002) | 7.17287535 |
| 5 | Petechiae (HP:0000967) | 6.84723514 |
| 6 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 6.69907736 |
| 7 | Fragile nails (HP:0001808) | 6.15179491 |
| 8 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.94340421 |
| 9 | Abnormality of DNA repair (HP:0003254) | 5.69304063 |
| 10 | Prolonged bleeding time (HP:0003010) | 5.55992466 |
| 11 | Purpura (HP:0000979) | 5.47889283 |
| 12 | Prominent metopic ridge (HP:0005487) | 5.21242214 |
| 13 | Abnormality of subcutaneous fat tissue (HP:0001001) | 5.17636761 |
| 14 | Erythroderma (HP:0001019) | 5.15104749 |
| 15 | Generalized aminoaciduria (HP:0002909) | 4.63576383 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 4.59279760 |
| 17 | Abnormality of the metopic suture (HP:0005556) | 4.38918060 |
| 18 | Menorrhagia (HP:0000132) | 4.27824456 |
| 19 | Abnormal platelet volume (HP:0011876) | 4.21686443 |
| 20 | Increased mean platelet volume (HP:0011877) | 4.15473097 |
| 21 | Epistaxis (HP:0000421) | 4.08880647 |
| 22 | Conjunctival hamartoma (HP:0100780) | 3.85752881 |
| 23 | Brittle hair (HP:0002299) | 3.75971261 |
| 24 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.41056646 |
| 25 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.41056646 |
| 26 | Death in childhood (HP:0003819) | 3.41007203 |
| 27 | Gingival bleeding (HP:0000225) | 3.40223252 |
| 28 | Male infertility (HP:0003251) | 3.37097551 |
| 29 | Abnormal platelet function (HP:0011869) | 3.17015445 |
| 30 | Impaired platelet aggregation (HP:0003540) | 3.17015445 |
| 31 | Cone-rod dystrophy (HP:0000548) | 3.13916268 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 3.10750011 |
| 33 | Obstructive lung disease (HP:0006536) | 3.05885591 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05885591 |
| 35 | Ectropion (HP:0000656) | 3.01291465 |
| 36 | Progressive macrocephaly (HP:0004481) | 2.92065787 |
| 37 | Abnormality of the costochondral junction (HP:0000919) | 2.90790329 |
| 38 | Abnormality of renal resorption (HP:0011038) | 2.82645543 |
| 39 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.78084804 |
| 40 | Dysostosis multiplex (HP:0000943) | 2.76802344 |
| 41 | Recurrent corneal erosions (HP:0000495) | 2.75879956 |
| 42 | Hypophosphatemic rickets (HP:0004912) | 2.75305507 |
| 43 | Abnormal pupillary function (HP:0007686) | 2.72154410 |
| 44 | Stomatitis (HP:0010280) | 2.69368359 |
| 45 | IgG deficiency (HP:0004315) | 2.64379716 |
| 46 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.61815805 |
| 47 | Increased serum ferritin (HP:0003281) | 2.60240444 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55677012 |
| 49 | Acute necrotizing encephalopathy (HP:0006965) | 2.47649496 |
| 50 | Abnormality of iron homeostasis (HP:0011031) | 2.45927622 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.45828434 |
| 52 | Bone cyst (HP:0012062) | 2.45811844 |
| 53 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.42351549 |
| 54 | Progressive neurologic deterioration (HP:0002344) | 2.39451065 |
| 55 | Keratitis (HP:0000491) | 2.38837740 |
| 56 | Increased IgM level (HP:0003496) | 2.38019979 |
| 57 | Hepatocellular necrosis (HP:0001404) | 2.37688251 |
| 58 | Hepatic necrosis (HP:0002605) | 2.37202601 |
| 59 | Failure to thrive in infancy (HP:0001531) | 2.35084811 |
| 60 | Stomach cancer (HP:0012126) | 2.33229450 |
| 61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.28991707 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.23826073 |
| 63 | Abnormal number of erythroid precursors (HP:0012131) | 2.22199988 |
| 64 | Type I transferrin isoform profile (HP:0003642) | 2.21334479 |
| 65 | Recurrent abscess formation (HP:0002722) | 2.20824274 |
| 66 | Aplastic anemia (HP:0001915) | 2.19880329 |
| 67 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19848643 |
| 68 | Hypertensive crisis (HP:0100735) | 2.19824453 |
| 69 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.18390423 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 2.18173661 |
| 71 | Glycosuria (HP:0003076) | 2.18173661 |
| 72 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.16785994 |
| 73 | Abnormality of lateral ventricle (HP:0030047) | 2.16096100 |
| 74 | Lactic acidosis (HP:0003128) | 2.16039018 |
| 75 | Cerebral edema (HP:0002181) | 2.15898862 |
| 76 | Acute encephalopathy (HP:0006846) | 2.15076412 |
| 77 | Episodic fever (HP:0001954) | 2.14328763 |
| 78 | Increased hepatocellular lipid droplets (HP:0006565) | 2.12804271 |
| 79 | Loss of speech (HP:0002371) | 2.12533057 |
| 80 | Increased CSF lactate (HP:0002490) | 2.10131948 |
| 81 | Axonal loss (HP:0003447) | 2.09016269 |
| 82 | Multiple lipomas (HP:0001012) | 2.08970954 |
| 83 | Lipid accumulation in hepatocytes (HP:0006561) | 2.07395216 |
| 84 | Neonatal respiratory distress (HP:0002643) | 2.06722635 |
| 85 | Abnormality of glycolipid metabolism (HP:0010969) | 2.04774869 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.04774869 |
| 87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.04774869 |
| 88 | Paralysis (HP:0003470) | 2.04215929 |
| 89 | Distal lower limb muscle weakness (HP:0009053) | 2.04104800 |
| 90 | Exertional dyspnea (HP:0002875) | 2.02442210 |
| 91 | Choreoathetosis (HP:0001266) | 2.02200176 |
| 92 | Spontaneous hematomas (HP:0007420) | 2.01194208 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01087587 |
| 94 | Muscle fibrillation (HP:0010546) | 1.98849034 |
| 95 | Tongue fasciculations (HP:0001308) | 1.95820257 |
| 96 | Increased cerebral lipofuscin (HP:0011813) | 1.95598076 |
| 97 | Hyperlipoproteinemia (HP:0010980) | 1.94690859 |
| 98 | Hyperthyroidism (HP:0000836) | 1.94542224 |
| 99 | Megalencephaly (HP:0001355) | 1.93903144 |
| 100 | Albinism (HP:0001022) | 1.93634430 |
| 101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91519430 |
| 102 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.90438258 |
| 103 | Amyloidosis (HP:0011034) | 1.90293987 |
| 104 | Cholecystitis (HP:0001082) | 1.89671413 |
| 105 | Abnormal gallbladder physiology (HP:0012438) | 1.89671413 |
| 106 | Angiofibromas (HP:0010615) | 1.88554716 |
| 107 | Adenoma sebaceum (HP:0009720) | 1.88554716 |
| 108 | Abnormal protein glycosylation (HP:0012346) | 1.87718676 |
| 109 | Abnormal glycosylation (HP:0012345) | 1.87718676 |
| 110 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87718676 |
| 111 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87718676 |
| 112 | Dicarboxylic aciduria (HP:0003215) | 1.87302809 |
| 113 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87302809 |
| 114 | Premature rupture of membranes (HP:0001788) | 1.86993868 |
| 115 | Mucosal telangiectasiae (HP:0100579) | 1.86829395 |
| 116 | Urticaria (HP:0001025) | 1.85417863 |
| 117 | Spastic paraparesis (HP:0002313) | 1.84728327 |
| 118 | Myositis (HP:0100614) | 1.83868772 |
| 119 | Cerebral hypomyelination (HP:0006808) | 1.83857547 |
| 120 | Hypokinesia (HP:0002375) | 1.83051182 |
| 121 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.82751734 |
| 122 | Recurrent bacterial skin infections (HP:0005406) | 1.82478954 |
| 123 | Muscle fiber splitting (HP:0003555) | 1.81157943 |
| 124 | Ventricular tachycardia (HP:0004756) | 1.80952892 |
| 125 | Increased serum lactate (HP:0002151) | 1.80167939 |
| 126 | Ragged-red muscle fibers (HP:0003200) | 1.80166760 |
| 127 | Increased muscle lipid content (HP:0009058) | 1.78955046 |
| 128 | Thrombocytosis (HP:0001894) | 1.78806895 |
| 129 | Systemic lupus erythematosus (HP:0002725) | 1.78804092 |
| 130 | Vertebral compression fractures (HP:0002953) | 1.77970262 |
| 131 | Respiratory failure (HP:0002878) | 1.77341273 |
| 132 | Recurrent fungal infections (HP:0002841) | 1.77140223 |
| 133 | Cutaneous photosensitivity (HP:0000992) | 1.76470457 |
| 134 | Opisthotonus (HP:0002179) | 1.75317497 |
| 135 | Bruising susceptibility (HP:0000978) | 1.74741603 |
| 136 | Poor head control (HP:0002421) | 1.74471133 |
| 137 | Increased intramyocellular lipid droplets (HP:0012240) | 1.74185613 |
| 138 | Cerebral palsy (HP:0100021) | 1.73765937 |
| 139 | Hamartoma of the eye (HP:0010568) | 1.73199081 |
| 140 | Nausea (HP:0002018) | 1.72887556 |
| 141 | Progressive visual loss (HP:0000529) | 1.71985721 |
| 142 | Abnormality of the anterior horn cell (HP:0006802) | 1.70493647 |
| 143 | Cavernous hemangioma (HP:0001048) | 1.65557876 |
| 144 | Maternal diabetes (HP:0009800) | 1.65022131 |
| 145 | Prolonged neonatal jaundice (HP:0006579) | 1.61331875 |
| 146 | Testicular atrophy (HP:0000029) | 1.60624976 |
| 147 | Hepatosplenomegaly (HP:0001433) | 1.60586498 |
| 148 | Exercise intolerance (HP:0003546) | 1.60515136 |
| 149 | Eczematoid dermatitis (HP:0000976) | 1.58716592 |
| 150 | Rough bone trabeculation (HP:0100670) | 1.56232613 |
| 151 | Abnormal drinking behavior (HP:0030082) | 1.55938987 |
| 152 | Polydipsia (HP:0001959) | 1.55938987 |
| 153 | Mesangial abnormality (HP:0001966) | 1.55886131 |
| 154 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.54642597 |
| 155 | Rocker bottom foot (HP:0001838) | 1.53252981 |
| 156 | Arthrogryposis multiplex congenita (HP:0002804) | 1.52368444 |
| 157 | Deep palmar crease (HP:0006191) | 1.52300718 |
| 158 | Abnormality of the septum pellucidum (HP:0007375) | 1.52224198 |
| 159 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.52224182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK2 | 5.68995420 |
| 2 | BUB1 | 5.19402810 |
| 3 | NME2 | 4.43103430 |
| 4 | BRAF | 4.13353149 |
| 5 | VRK2 | 4.03759063 |
| 6 | PINK1 | 3.84519195 |
| 7 | PIM2 | 2.85719969 |
| 8 | MAP2K2 | 2.74461526 |
| 9 | TAOK1 | 2.60541263 |
| 10 | STK16 | 2.31998232 |
| 11 | LIMK1 | 2.27892795 |
| 12 | MST4 | 2.07058286 |
| 13 | TESK2 | 2.06485986 |
| 14 | BLK | 1.85450233 |
| 15 | IRAK3 | 1.80695919 |
| 16 | MAP3K3 | 1.80486953 |
| 17 | GRK6 | 1.74959875 |
| 18 | TAOK2 | 1.66536756 |
| 19 | BMX | 1.63428702 |
| 20 | MAP3K8 | 1.63321103 |
| 21 | IRAK4 | 1.62237507 |
| 22 | ABL2 | 1.60207979 |
| 23 | ARAF | 1.53431993 |
| 24 | EPHB1 | 1.53144858 |
| 25 | MAP3K12 | 1.50993561 |
| 26 | CSF1R | 1.43422651 |
| 27 | ILK | 1.36492650 |
| 28 | BCKDK | 1.35086894 |
| 29 | TESK1 | 1.34034323 |
| 30 | SIK3 | 1.33346932 |
| 31 | BTK | 1.31497880 |
| 32 | MAPKAPK3 | 1.21041754 |
| 33 | DAPK1 | 1.19950995 |
| 34 | BMPR1B | 1.18159451 |
| 35 | ERN1 | 1.15842183 |
| 36 | TLK1 | 1.13676153 |
| 37 | KDR | 1.13613940 |
| 38 | CLK1 | 1.11939503 |
| 39 | FGR | 1.11490781 |
| 40 | MYLK | 1.10503233 |
| 41 | TTN | 1.09438086 |
| 42 | WEE1 | 1.08957845 |
| 43 | PTK2B | 1.06829790 |
| 44 | TEC | 1.06591431 |
| 45 | LMTK2 | 1.06533443 |
| 46 | TBK1 | 1.05016914 |
| 47 | NME1 | 1.04421124 |
| 48 | DMPK | 1.04125697 |
| 49 | DYRK2 | 1.02910929 |
| 50 | CDK19 | 1.00755909 |
| 51 | DAPK3 | 0.99175214 |
| 52 | SCYL2 | 0.97729834 |
| 53 | INSRR | 0.94579190 |
| 54 | PBK | 0.91682414 |
| 55 | MAP4K1 | 0.90350896 |
| 56 | VRK1 | 0.88927421 |
| 57 | PAK4 | 0.84913928 |
| 58 | TRIB3 | 0.81528876 |
| 59 | STK4 | 0.81263011 |
| 60 | DYRK3 | 0.76794435 |
| 61 | KIT | 0.76039487 |
| 62 | ZAP70 | 0.75657404 |
| 63 | HCK | 0.75554116 |
| 64 | EIF2AK1 | 0.74592127 |
| 65 | PDK3 | 0.74494040 |
| 66 | PDK4 | 0.74494040 |
| 67 | AURKA | 0.74416594 |
| 68 | FES | 0.74127781 |
| 69 | GRK7 | 0.74051749 |
| 70 | JAK3 | 0.72937846 |
| 71 | LRRK2 | 0.72928260 |
| 72 | WNK4 | 0.71866281 |
| 73 | FLT3 | 0.71714564 |
| 74 | PHKG2 | 0.70571185 |
| 75 | PHKG1 | 0.70571185 |
| 76 | PKN2 | 0.68249662 |
| 77 | MAP3K1 | 0.68087008 |
| 78 | PAK1 | 0.67982191 |
| 79 | EPHA2 | 0.67457169 |
| 80 | OBSCN | 0.65834689 |
| 81 | IKBKB | 0.63871803 |
| 82 | TXK | 0.63505377 |
| 83 | BMPR2 | 0.63445846 |
| 84 | SMG1 | 0.62957180 |
| 85 | ADRBK2 | 0.62604911 |
| 86 | PRKD2 | 0.61196030 |
| 87 | PRKG2 | 0.60234067 |
| 88 | PDK2 | 0.59988111 |
| 89 | RIPK4 | 0.59050482 |
| 90 | PLK4 | 0.58027846 |
| 91 | MAP4K2 | 0.57918674 |
| 92 | PRKD1 | 0.55050598 |
| 93 | LYN | 0.54359868 |
| 94 | TGFBR1 | 0.54109236 |
| 95 | STK10 | 0.53599116 |
| 96 | IRAK1 | 0.52576476 |
| 97 | CDK8 | 0.51283537 |
| 98 | CAMK2D | 0.50819235 |
| 99 | MAP3K5 | 0.48651627 |
| 100 | NUAK1 | 0.48234320 |
| 101 | RPS6KA4 | 0.46352035 |
| 102 | IKBKE | 0.45835396 |
| 103 | CSNK1G3 | 0.45484923 |
| 104 | TYK2 | 0.45082850 |
| 105 | SYK | 0.44239265 |
| 106 | MKNK2 | 0.44184709 |
| 107 | PIK3CG | 0.43596445 |
| 108 | CDK14 | 0.43482313 |
| 109 | PDPK1 | 0.43181785 |
| 110 | SIK1 | 0.42773218 |
| 111 | ADRBK1 | 0.42267285 |
| 112 | MAP2K6 | 0.41605620 |
| 113 | CAMK2G | 0.39509170 |
| 114 | NEK9 | 0.39202890 |
| 115 | TGFBR2 | 0.38897903 |
| 116 | PRKCD | 0.38341646 |
| 117 | CSK | 0.38290692 |
| 118 | MARK3 | 0.36596408 |
| 119 | CDK7 | 0.36557307 |
| 120 | GRK5 | 0.34838448 |
| 121 | PRKCI | 0.34497623 |
| 122 | NEK1 | 0.34442099 |
| 123 | ROCK2 | 0.32735733 |
| 124 | MAPKAPK2 | 0.31456542 |
| 125 | CASK | 0.31204679 |
| 126 | NTRK1 | 0.30918074 |
| 127 | EIF2AK3 | 0.30878134 |
| 128 | TRIM28 | 0.30149844 |
| 129 | TRPM7 | 0.29718184 |
| 130 | LCK | 0.28897513 |
| 131 | MAP3K11 | 0.28750733 |
| 132 | PRKCE | 0.27991372 |
| 133 | MAP2K3 | 0.27119706 |
| 134 | MET | 0.25936260 |
| 135 | CSNK2A1 | 0.25330322 |
| 136 | TNK2 | 0.24824937 |
| 137 | MATK | 0.24695187 |
| 138 | MKNK1 | 0.23523859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RNA polymerase_Homo sapiens_hsa03020 | 4.41038782 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.90798304 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.89742466 |
| 4 | Nucleotide excision repair_Homo sapiens_hsa03420 | 3.71735377 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.67672707 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.95576341 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.71354254 |
| 8 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.65595589 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.62405419 |
| 10 | Basal transcription factors_Homo sapiens_hsa03022 | 2.49334312 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.41012839 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 2.26497522 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.14274594 |
| 14 | Protein export_Homo sapiens_hsa03060 | 2.01120471 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.98342054 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97890436 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94793111 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.90960564 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.88550258 |
| 20 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.84356216 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.63608992 |
| 22 | Platelet activation_Homo sapiens_hsa04611 | 1.63218446 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55083574 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.53089033 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.49255592 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.47290887 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46183490 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45415998 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41334721 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33277083 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26715775 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23498328 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15882955 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15674986 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.13329111 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.12258545 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09742247 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05685364 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03446382 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01899008 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01333523 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98264767 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.95976660 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 0.94046210 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92222769 |
| 46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.91876341 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91061593 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88844674 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87685512 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.85748295 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84495995 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82028160 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81512634 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.79936198 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79828253 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79435459 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77387465 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76876328 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74458895 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73764692 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73753953 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69037063 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.68651695 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66641294 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66125944 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65617339 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64595950 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63406930 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61439717 |
| 70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60263077 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60094249 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.59616568 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59236693 |
| 74 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58406432 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56583743 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.55644734 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54382466 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54027853 |
| 79 | Melanoma_Homo sapiens_hsa05218 | 0.52207113 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.50057356 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49284619 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48669235 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48643120 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47891973 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45847759 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45801597 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44348389 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42783588 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.40837896 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40518836 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.40267526 |
| 92 | Spliceosome_Homo sapiens_hsa03040 | 0.39530825 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39472541 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.39433671 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39393933 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39055188 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38533711 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38146424 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37757156 |
| 100 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36101927 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.35967128 |
| 102 | RNA transport_Homo sapiens_hsa03013 | 0.35732405 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.34639052 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34498855 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34317609 |
| 106 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34299352 |
| 107 | Tuberculosis_Homo sapiens_hsa05152 | 0.33484757 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32639038 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32356512 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31550396 |
| 111 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31210424 |
| 112 | Allograft rejection_Homo sapiens_hsa05330 | 0.30975218 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29939989 |
| 114 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29016172 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.28551118 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28452984 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27998831 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27560566 |
| 119 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.27231715 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27100035 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25005359 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.24619664 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24298325 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21702306 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21035606 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20429750 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.19811777 |
| 128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.19276060 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.17053999 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.16969559 |

